logo-loader
EuroLife Brands

Cannvas MedTech raises C$1 million after closing on first tranche of private placement

The Toronto-based cannabis education and analytics company issued a total of 5,007,500 units at a price of C$0.20 per unit

cannabis
Cannvas said it intends to use the proceeds for developing the technology platforms and general working capital

Cannvas MedTech Inc (CSE: MTEC) (OTCPK:CANVF) announced Tuesday it has raised slightly more than C$1 million after closing on the first tranche of a non‑brokered private placement.

The Toronto-based cannabis education and analytics company issued a total of 5,007,500 units at a price of C$0.20 per unit. 

Each unit consists of one common share and one transferable common share purchase warrant exercisable at C$0.30 per share for a period of two years.

READ: Cannvas MedTech says planned expansion into Europe is on track; plans to raise C$2M

Cannvas said it intends to use the proceeds for developing the technology platforms and general working capital.

The company anticipates closing the second and final tranche of the financing in short order.

Insiders of Cannvas subscribed for 275,000 units, including CEO Shawn Moniz, CEO (125,000 units), COO Steve Loutskou (125,000 units) and Lindsay Hamelin, a director of the company (25,000 units).

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: EuroLife Brands

Price: $0.11

Market: CSE
Market Cap: $21.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of EuroLife Brands named herein, including the promotion by the Company of EuroLife Brands in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks in the green; CB2 Insights gets boost from...

Buds today are CB2 Insights (CSE:CBII) (OTCQB:CBIIF), Cannvas MedTech Inc (CSE:MTEC) (OTCMKTS:CANVF). Duds are Canopy Growth Corp (TSE:WEED) (NYSE:CGC), Choom (CSE:CHOO) (OTCMKTS:CHOOF).

3 weeks, 1 day ago

2 min read